Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 8 (UBA52P8)

UBA52P8, or ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 8, is a human pseudogene that shares high sequence similarity to the functional UBA52 gene, which encodes a fusion protein linking ubiquitin with ribosomal protein L40[1][2]. Pseudogenes like UBA52P8 typically arise from past duplication or retrotransposition events and accumulate mutations leading to loss of functional protein coding capacity[4][5]. Most pseudogenes, including UBA52P8, are considered \"nonfunctional\" and are not capable of producing a functional protein product[4][5]. While some ubiquitin pseudogenes (e.g., UBBP4) have been shown to be transcribed and possibly translated into variant ubiquitin proteins with distinct functions, there is no strong evidence to suggest that UBA52P8 produces a functional RNA or protein in humans[3]. Its primary use is in genomic annotation rather than therapeutic research or drug development[1][2]. If you require information on functional ubiquitin genes or other true targets related to the ubiquitin-proteasome pathway (such as UBA52, UBC, UBB, or UBA1), those have well-documented roles in protein degradation, cell signaling, and disease processes—unlike pseudogenes such as UBA52P8[3].

None applicable. There are no approved or experimental drugs known to act via mechanisms involving UBA52P8.